Pharmaceutical composition comprising a mixture of carboxylated oligopeptides

摘要

A pharmaceutical composition comprising a mixture of carboxylated oligopeptides, derived by hydrolysis of eukaryotic or prokaryotic cells and their subsequent partial carboxylation through acylation or alkylation of the amino acid and basic amino acid residues in the amino terminal structure of the oligopeptides. The resulting pharmaceutical composition can be used in production of medical drugs effective in the treatment of cancer, pancreatitis, viral infection, for the development of vaccines.

主权项

1. A pharmaceutical composition, comprising a mixture of carboxylated oligopeptides, produced by enzymatic hydrolysis of natural polypeptides, that resulted in a oligopeptide mixture ranging of 2 to 30 amino acid residues, having free amino groups in the oligopeptide mixture and then carboxylated.